[1] |
NETO JS, FONSECA EA, VINCENZI R, et al. Technical choices in pediatric living donor liver transplantation: The path to reduce vascular complications and improve survival[J]. Liver Transpl, 2020, 26(12): 1644-1651. DOI: 10.1002/lt.25875.
|
[2] |
ZHONG J, SMITH C, WALKER P, et al. Imaging post liver transplantation part Ⅰ: Vascular complications[J]. Clin Radiol, 2020, 75(11): 845-853. DOI: 10.1016/j.crad.2020.06.007.
|
[3] |
JU WQ, HE XS, GUO ZY, et al. Diagnosis and treatment of early-stage hepatic artery thrombosis after adult liver transplantation[J]. Chin J Hepatobiliary Surg, 2012, 18(1): 19-22. DOI: 10.3760/cma.j.issn.1007-8118.2012.01.006.
鞠卫强, 何晓顺, 郭志勇, 等. 成人肝移植术后早期肝动脉血栓形成的诊断与治疗[J]. 中华肝胆外科杂志, 2012, 18(1): 19-22. DOI: 10.3760/cma.j.issn.1007-8118.2012.01.006.
|
[4] |
HEATON ND. Hepatic artery thrombosis: Conservative management or retransplantation?[J]. Liver Transpl, 2013, 19(Suppl 2): s14-s16. DOI: 10.1002/lt.23739.
|
[5] |
DELGADO-MORALEDA JJ, BALLESTER-VALLÉS C, MARTI-BONMATI L. Role of imaging in the evaluation of vascular complications after liver transplantation[J]. Insights Imaging, 2019, 10(1): 78. DOI: 10.1186/s13244-019-0759-x.
|
[6] |
FRONGILLO F, LIROSI MC, NURE E, et al. Diagnosis and management of hepatic artery complications after liver transplantation[J]. Transplant Proc, 2015, 47(7): 2150-2155. DOI: 10.1016/j.transproceed.2014.11.068.
|
[7] |
PAWLAK J, GRODZICKI M, LEOWSKA E, et al. Vascular complications after liver transplantation[J]. Transplant Proc, 2003, 35(6): 2313-2315. DOI: 10.1016/s0041-1345(03)00836-4.
|
[8] |
GAO HJ, CHEN G, WANG H, et al. Cover-stent and embolization treatment of hepatic artery pseudoaneurysm following liver transplantation[J]. Chin J Hepatobiliary Surg, 2014, 20(1): 29-31. DOI: 10.3760/cma.j.issn.1007-8118.2014.01.008.
高海军, 陈光, 王浩, 等. 栓塞和支架治疗肝移植术后肝动脉假性动脉瘤[J]. 中华肝胆外科杂志, 2014, 20(1): 29-31. DOI: 10.3760/cma.j.issn.1007-8118.2014.01.008.
|
[9] |
GRIMALDI C, DI FRANCESCO F, CHIUSOLO F, et al. Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome[J]. Pediatr Transplant, 2018, 22(8): e13288. DOI: 10.1111/petr.13288.
|
[10] |
SAAD WE. Nonocclusive hepatic artery hypoperfusion syndrome (splenic steal syndrome) in liver transplant recipients[J]. Semin Intervent Radiol, 2012, 29(2): 140-146. DOI: 10.1055/s-0032-1312576.
|
[11] |
WOJCICKI M, PAKOSZ-GOLANOWSKA M, LUBIKOWSKI J, et al. Direct pressure measurement in the hepatic artery during liver transplantation: Can it prevent the "steal" syndrome?[J]. Clin Transplant, 2012, 26(2): 223-228. DOI: 10.1111/j.1399-0012.2011.01478.x.
|
[12] |
GRIESER C, DENECKE T, STEFFEN IG, et al. Multidetector computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation[J]. Eur Radiol, 2010, 20(1): 108-117. DOI: 10.1007/s00330-009-1535-y.
|
[13] |
ZOU WL, ZHANG W, REN XY, et al. Diagnosis, prophylaxis and treatment of splenic arterial steal syndrome after orthotopic liver transplantation[J]. Chin J Hepatobiliary Surg, 2015, 21(6): 382-387. DOI: 10.3760/cma.j.issn.1007-8118.2015.06.006.
邹卫龙, 张薇, 任秀昀, 等. 肝移植术后脾动脉盗血综合征的诊断和防治[J]. 中华肝胆外科杂志, 2015, 21(6): 382-387. DOI: 10.3760/cma.j.issn.1007-8118.2015.06.006.
|
[14] |
DOKMAK S, AUSSILHOU B, BELGHITI J. Liver transplantation and splenic artery steal syndrome: The diagnosis should be established preoperatively[J]. Liver Transpl, 2013, 19(6): 667-668. DOI: 10.1002/lt.23639.
|
[15] |
GARCÍA-CRIADO A, GILABERT R, BIANCHI L, et al. Impact of contrast-enhanced ultrasound in the study of hepatic artery hypoperfusion shortly after liver transplantation: Contribution to the diagnosis of artery steal syndrome[J]. Eur Radiol, 2015, 25(1): 196-202. DOI: 10.1007/s00330-014-3377-5.
|
[16] |
RATHER SA, NAYEEM MA, AGARWAL S, et al. Vascular complications in living donor liver transplantation at a high-volume center: Evolving protocols and trends observed over 10 years[J]. Liver Transpl, 2017, 23(4): 457-464. DOI: 10.1002/lt.24682.
|
[17] |
CHEN WZ, ZHANG SN, ZHONG YM, et al. Percutaneous intravascular interventional treatment of portal venous complications after liver transplantation[J]. J Imag Res Med Appl, 2020, 4(13): 34-37. DOI: 10.3969/j.issn.2096-3807.2020.13.017.
陈文忠, 张升宁, 钟粤明, 等. 肝移植术后门静脉系统并发症的血管内介入治疗[J]. 影像研究与医学应用, 2020, 4(13): 34-37. DOI: 10.3969/j.issn.2096-3807.2020.13.017.
|
[18] |
VÄLI T, TEIN A, TIGANIK V, et al. Vascular complications after orthotopic liver transplantation in Estonia[J]. Transplant Proc, 2013, 45(3): 1201-1203. DOI: 10.1016/j.transproceed.2012.10.011.
|
[19] |
KHOSLA A, FETZER D, REIS S, et al. Vascular complications following liver transplantation: Diagnosis and intervention[J]. Contemporary Diagnostic Radiology, 2016, 39(26): 1-6. DOI: 10.1097/01.CDR.0000510765.59561.51.
|
[20] |
FAN L, ZHANG QY, XIONG Y, et al. Progress of digital subtraction angiography in treatment of vascular complications after liver transplantation[J]. Chin J Hepatobiliary Surg, 2015, 21(1): 63-67. DOI: 10.3760/cma.j.issn.1007-8118.2015.01.020.
范林, 张秋艳, 熊艳, 等. 肝移植术后血管并发症介入治疗的进展[J]. 中华肝胆外科杂志, 2015, 21(1): 63-67. DOI: 10.3760/cma.j.issn.1007-8118.2015.01.020.
|
[1] | Zongqi DENG, Wenlin TAI. Role of macrophages in the development and progression of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1924-1928. doi: 10.12449/JCH240932 |
[2] | Qiupeng WANG, Meifu GAN. Pathological diagnosis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1088-1092. doi: 10.12449/JCH240604 |
[3] | Yujie QIN, Wenxiu ZHOU, Xingnian ZHOU, Mingliang CHENG, Hong LI. Report and genetic analysis of autoimmune liver diseases between mother and daughter[J]. Journal of Clinical Hepatology, 2023, 39(2): 387-391. doi: 10.3969/j.issn.1001-5256.2023.02.021 |
[4] | Lin HAN, Qingsheng LIANG, Huan XIE, Ying CHEN, Jun ZHAO, Mingyue ZHANG, Baosen LI, Yanli DONG, Ying SUN. Value of baseline IgM level in predicting the treatment response of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(4): 815-820. doi: 10.3969/j.issn.1001-5256.2022.04.015 |
[5] | Xinhang SONG, Juanhan YU, Zhaoping CHENG, Chen SHAO, Baocheng DENG. Pathological staging systems of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(3): 653-655. doi: 10.3969/j.issn.1001-5256.2022.03.033 |
[6] | Fang QIU, Chan WANG, Mingming ZHANG, Xingjuan SHI, Xiangdong LIU. Genetic studies of primary biliary cholangitis in the post-GWAS era[J]. Journal of Clinical Hepatology, 2022, 38(4): 759-761. doi: 10.3969/j.issn.1001-5256.2022.04.005 |
[7] | Xing LYU, Ting LI, Xiaodong SUN, Jianpeng ZHOU, Dongxia WANG, Guoyue LYU. Research advances in the treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(9): 2130-2135. doi: 10.3969/j.issn.1001-5256.2022.09.035 |
[8] | Haitao MA, Yingmei TANG. Research advances in exosomes in primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(8): 1896-1900. doi: 10.3969/j.issn.1001-5256.2022.08.035 |
[9] | Jing ZHU, Yanhang GAO. Recommendations for APASL clinical practice guidance: The diagnosis and management of patients with primary biliary cholangitis (2022)[J]. Journal of Clinical Hepatology, 2022, 38(2): 318-319. doi: 10.3969/j.issn.1001-5256.2022.02.012 |
[10] | Ma WeiYu, Deng ZhiHua. Current status of immunogenetic studies on primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 932-935. doi: 10.3969/j.issn.1001-5256.2020.04.050 |
[11] | Huang ZhiQin, Huang HuiFang. Research advances in cytokines associated with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(2): 446-450. doi: 10.3969/j.issn.1001-5256.2020.02.047 |
[12] | Tu RongFang, Yang Xue, Tang YingMei. Research advances in primary biliary cholangitis with extrahepatic autoimmune diseases[J]. Journal of Clinical Hepatology, 2020, 36(6): 1398-1401. doi: 10.3969/j.issn.1001-5256.2020.06.046 |
[13] | Xu Li, Zheng YueQi, Shi Zhen, Chen YiYun, Shao HuiJiang, Chen JianJie. Influencing factors for the prognosis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1870-1873. doi: 10.3969/j.issn.1001-5256.2019.08.050 |
[14] | Qu Yao, Zhang Wei. Role of cell apoptosis in the pathogenesis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1397-1400. doi: 10.3969/j.issn.1001-5256.2019.06.049 |
[15] | Li ShuXiang, Duan WeiJia, Zhang Dong, You Hong, Jia JiDong. Research advances in autoimmune hepatitis and primary biliary cholangitis in 2017[J]. Journal of Clinical Hepatology, 2018, 34(7): 1569-1572. doi: 10.3969/j.issn.1001-5256.2018.07.044 |
[16] | Li Dong, Lu ZhongHua, Gan JianHe. Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance[J]. Journal of Clinical Hepatology, 2016, 32(5): 928-932. doi: 10.3969/j.issn.1001-5256.2016.05.025 |
[17] | Fan ZhiDong, You JinLi. Diagnosis and treatment procedure for intractable liver ascites[J]. Journal of Clinical Hepatology, 2015, 31(3): 472-474. doi: 10.3969/j.issn.1001-5256.2015.03.039 |
[18] | Huang HaiYan, Xin YongNing, Jiang Man, Jin WenWen, Jiang XiangJun, Xuan ShiYing. Research advances in animal models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(9): 948-953. doi: 10.3969/j.issn.1001-5256.2014.09.028 |
[19] | Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272. |
[20] | Lou GuoHua, Liu YanNing, Yin ChunBen, Chen Feng, Jia ZhanSheng, Chen Zhi. Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J]. Journal of Clinical Hepatology, 2011, 27(1): 72-75. |